Pressemitteilungen

• 2022-12-01 Non-regulatory

  NeoDynamics appoints Matthew Colpoys, to lead US operations

  Weiterlesen

• 2022-11-17 Regulatory

  NeoDynamics Interim Report January-September 2022

  Weiterlesen

• 2022-11-16 Non-regulatory

  NeoDynamics gears up for US launch by partnering with Diligent

  Weiterlesen

• 2022-11-08 Non-regulatory

  NeoDynamics hires National Sales Director for the launch of its NeoNavia® Biopsy System

  Weiterlesen

• 2022-10-25 Non-regulatory

  Changing Breast Cancer Treatment with the NeoNavia[®] Biopsy System

  Weiterlesen

• 2022-10-20 Non-regulatory

  NeoDynamics to present at Redeye’s Medtech Seminar on October 26

  Weiterlesen

• 2022-09-21 Non-regulatory

  NeoDynamics appoints Decomplix as Swiss representative

  Weiterlesen

• 2022-09-08 Regulatory

  NeoDynamics received FDA clearance for pulse biopsy system NeoNavia®

  Weiterlesen

• 2022-08-18 Regulatory

  NeoDynamics Interim Report Jan-June 2022

  Weiterlesen

• 2022-08-16 Non-regulatory

  Meet NeoDynamics Matt E. Colpoys

  Weiterlesen

• 2022-07-07 Non-regulatory

  NeoDynamics receives ethical approval for German device registry

  Weiterlesen

• 2022-06-17 Non-regulatory

  Gryningskust Holding AB increases ownership in NeoDynamics

  Weiterlesen

• 2022-06-09 Non-regulatory

  Update on the FDA approval process for NeoNavia®

  Weiterlesen